Abstract
Ductal adenocarcinoma, a solid, exocrine epithelial neoplasm, represents with its variations the large majority of primitive malignant tumors of the pancreas (about 90% of cases) [1]. It is typically characterized by insidious growth with a generally unfavorable prognosis. At the time of diagnosis in most cases there are already peripancreatic lymph node metastases, and at post mortem, liver (80%), peritoneal (60%), pulmonary (50–70%), and suprarenal metastases (25%) are also frequently found [2]. Despite the recent knowledge acquired in the biomolecular genetics of this neoplasm and the progress made in instrumental diagnostic technology, the prognosis of this tumor is still poor, with an average survival of 19% at 1 year after diagnosis and 2–4% after 5 years: pancreatic cancer still has the worst prognosis of the solid neoplasms [3].
Keywords
- Pancreatic Cancer
- Hepatocyte Growth Factor
- Pancreatic Carcinoma
- Pancreatic Adenocarcinoma
- Uncinate Process
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Yeo CJ (1998) Pancreatic cancer: 1998 Update. Am J Coll Surg; 187:429
Cotran RS, Kumar V, Collins T (2000) Robbins: le basi patologiche delle malattie. Piccin Editore, Padova
Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas — 616 patients: results, outcomes and prognostic indicators. J Gastrointest Surg 4:567
Solcia E, Capella C, Kloppel G (1997) Tumor of the pancreas. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington DC, USA, p 26
Kloppel G, Solcia E, Longnecker DS et al (1998) Histological typing of tumors of the exocrine pancreas. In: WHO, International Histological Classification of Tumors. Springer, Berlin Heidelberg New York, p 24
Zamboni G, Capelli P, Pesci A et al (2000) Pancreatic head mass: what can be done? Classification: the pathological point of view. JOP 1:77
Li D, Xie K, Wolff R et al (2004) Pancreatic cancer. Lancet 363:1049
Kloppel G (1984) Pancreatic, non-endocrine tumors. In: Kloppel G, Heitz PH (eds) Pancreatic pathology. Churchill Livingstone, New York, p 79
Takaori K, Hruban RH, Maitra A et al (2006) Current topics on precursors to pancreatic cancer. Adv Med Sci 51:23
Takaori K (2007) Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg 14:217
Hruban RH, Fukushima N (2007) Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs. Mod Pathol 20:61
Brat DJ, Lillemoe KD, Yeo CJ et al (1998) Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 22:163
Wilentz RE, Iacobuzio-Donahue CA, Argani P et al (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60:2002
Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathos 25:579
Bianco AR (2003) Manuale di oncologia clinica. McGraw-Hill, Milan
Zhang L, Sanderson SO, Lloyd RV et al (2007) Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Am J Surg Pathol 31:1191
Sanada Y, Yoshida (2007) Immunohistochemical analyses in intraductal gradually transitional components is useful for evaluation of stepwise progression of pancreatic intraepithelial neoplasia. Pancreas 35:101
Koorstra JB, Feldmann G, Habbe N et al (2008) Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs). Langenbecks Arch Surg 393:561
Gleave M, Hsieh JT, Gao CA et al (1991) Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51:375
Nakamura T, Matsumoto K, Kiritoshi A et al (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57:3305
Janvier R, Sourla A, Koutsilieris M et al (1997) Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system. Anticancer Res 17:1551
Anderson IC, Mari SE, Broderick RJ et al (2000) The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast co-cultures. Cancer Res 60:269
Bhowmick NA, Chytil A, Plieth D et al (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848
De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429
Maehara N, Matsumoto K, Kuba K et al (2001) NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br J Cancer 84:864
Kimura W, Kuroda A, Makuuchi M (1998) Problems in the diagnosis and treatment of socalled mucin-producing tumor of the pancreas. Pancreas 16:363
Kuba K, Matsumoto K, Date K et al (2000) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60:6737
Tomioka D, Maehara N, Kuba K et al (2001) Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. ancer Res 61:7518
Pour PM (1995) The role of Langerhans islets in exocrine pancreatic cancer. Int J Pancreatol 17:217
Pour PM, Schmied B (1999) The link between exocrine pancreatic cancer and the endocrine pancreas. Int J Pancreatol 25:77
Schmied B, Liu G, Moyer MP et al: Induction of adenocarcinoma from hamster pancreatic islet cells treated with N-nitrosobis(2-oxopropyl)amine in vitro. Carcinogenesis 1999; 20:317
Pour PM, Pandey KK, Batra SK (2003) What is the origin of pancreatic adenocarcinoma? Mol Cancer 2:13
Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol 19:999
Batty GD, Shipley MJ, Marmot MG et al (2004) Diabetes status and post-load glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 15:873
Michaud DS (2004) Epidemiology of pancreatic cancer Minerva Chir 59:99
Coughlin SS, Calle EE, Teras LR et al (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160
Abe R, Donnelly SC, Peng T et al (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556
Gabbiani G (2003) The myofibroblast in wound healing and. fibrocontractive diseases. J Pathol 200:500
Direkze NC, Forbes SJ, Brittan M et al (2003) Multiple organ engraftment by bone-marrowderived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 21:514
Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. Clin Investig 112:1776
Lieubeau B, Heymann MF, Henry F et al (1999) Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 81:629
Ng IO, Lai EC, Ng MM et al (1992) Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70:45
Koong AC, Mehta VK, Le QT et al (2000) Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 48:919
Büchler P, Reber HA, Büchler M et al (2003) Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 26:56
Mauri P, Scarpa A, Nascimbeni AC et al (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 19:1125
Moniaux N, Chakraborty S, Yalniz M et al (2008) Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 98:1540
Sobin LH, Wittekind C (2002) TNM classification of malignant tumors. Wiley-Liss, New York
Isaji S, Kawarada Y, Uemoto S (2004) Classification of pancreatic cancer. Comparison of Japanese and UICC classifications. Pancreas 28:231
Balci NC, Semelka RC (2001) Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol 38:113
Furukawa H, Mukai K, Kosugeet T et al (1998) Non functioning islet cell tumors of the pancreas: clinical aspects in 16 patients. Jpn J Clin Oncol 28:255
D’Onofrio M, Zamboni G, Malagò R et al (2005) Pancreatic pathology. In: Quaia E (ed) Contrast media in ultrasonography. Springer, Berlin Heidelberg New York, p 335
Yeo CJ, Cameron JL (2003) Pancreas esocrino. In: Sabiston (ed) Trattato di Chirurgia. Antonio Delfino Editore, Rome, p 112
D’Onofrio M, Mansueto G, Vasori S et al (2003) Contrast enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 22:4413
Akahoshi K, Chijiiwa Y, Nakano I et al (1998) Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. r J Radiol 71:492
Rosch T, Dittler HJ, Strobel K et al (2000) Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 52:469
Nishiharu T, Yamashita Y, Abe Y et al (1999) Local extension of pancreatic carcinoma: assessment with thin section helical CT versus breath-hold fast MR imaging-ROC analysis. Radiology 212:445
Ragozzino A, Scaglione M (2000) Pancreatic head mass: what can be done? Diagnosis: magnetic resonance imaging. JOP 1:100
Schima W, Fugger R Schober E et al (2002) Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro CT. AJR Am J Roentgenol 179:717
Di Cesare E, Puglielli E, Nichelini O et al (2003) Malignant obstructive jaundice: comparison of MRCP and ERCP in the evaluation of distal lesions. Radiol Med 105:445
McNulty N, Francis I, Platt J et al (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature and pancreatic adenocarcinoma. Radiology 220:97
Yoshihiko F, Fumito F, Michiro S et al (2002) Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology 222:674
Hänninen E, Amthauer H, Hosten N et al (2002) Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 224:34
Horton KM (2002) Multidetector CT and three dimensional imaging of the pancreas: state of the art. J Gastrointest Surg 6:126
Di Candio G, Giulianotti PC (1997) Pancreas: imaging diagnostico e interventistico. Paletto, Milan
Boland GW, O’Malley ME, Saez M et al (1999) Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605
Tabuchi T, Itoh K, Ohshio G et al (1999) Tumor staging of pancreatic adenocarcinoma using early and latephase helical CT. AJR Am J Roentgenol 173:375
Lee JKT, Sagel SS (1998) Computed body tomography with MRI correlation. Lippincott-Raven, Philadelphia
Roche C, Hughes M, Garvey CJ et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180:475
Winternitz T, Habib H, Kiss K et al (2000) Pancreatic head mass: what can be done? diagnosis: computed tomography scan. JOP 1:95
Scaglione M, Pinto A, Romano S et al (2005) Using multidetector row computer tomography to diagnose and stage pancreatic carcinoma: the problems and possibilities. JOP 6:1
Prokesch RW, Chow LC, Beaulieu CF et al (2002) Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations — initial experience. Radiology 225:759
Klauss M, Mohr A, von Tengg-Kobligk H et al (2008) A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography. Pancreatology 23:204
Nakao A, Harada A, Nonami T et al (1995) Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 117:50
Lepanto L, Arzoumanian Y, Gianfelice D et al (2002) Helical CT with CT angiography in assessing periampullary neoplasm: identification of vascular invasion. Radiology 222:347
Loyer EM, David CL, Dubrow RA et al (1996) Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging 21:202
Lu DSK, Reber HA, Krasny RM et al (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin section helical CT. AJR Am J Roentgenol 168:1439
Lüttges J, Vogel I, Menke M et al (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433:237
Di Candio G, Giulianotti PC, Pietrabissa A et al: Ecografia intraoperatoria del pancreas. In: Ecografia in chirurgia. Modalità diagnostiche e terapeutiche. Paletto, Milano, 1997
White R, Winston C, Gonen M et al (2008) Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 206:445
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
de Sanctis, A., Rimini, M., Guerrieri, M. (2009). Pancreatic Cancer: Pathological Factors and TNM Staging. In: Surgical Treatment of Pancreatic Diseases. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-0856-4_15
Download citation
DOI: https://doi.org/10.1007/978-88-470-0856-4_15
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0855-7
Online ISBN: 978-88-470-0856-4
eBook Packages: MedicineMedicine (R0)